OPDUALAG: payments to doctors
Payments that named OPDUALAG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $350K
- Providers
- 5,677
- Transactions
- 18,620
- Average per transaction
- $19
The per-transaction average — $19 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,677 providers the average total is $62, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $248,915 | 71.1% |
| Bristol Myers Squibb | $101,258 | 28.9% |